VVOS - Vivos Therapeutics EPS misses by $0.08 beats on revenue November, 15 2021 04:20 PM Vivos Therapeutics Inc. Vivos Therapeutics (NASDAQ:VVOS): Q3 GAAP EPS of -$0.26 misses by $0.08. Revenue of $4.55M (+38.3% Y/Y) beats by $0.05M. Press Release For further details see: Vivos Therapeutics EPS misses by $0.08, beats on revenue